Summary
Global Markets Direct’s “ENZO BIOCHEM, INC - Financial and Strategic Analysis Review†is an in-depth business, strategic and financial analysis of ENZO BIOCHEM, INC The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Enzo Biochem, Inc. (Enzo Biochem), a life science and biotechnology company, is engaged in developing new products and technologies through harnessing of genetic processes. The company develops research tools, diagnostics, therapeutics and technologies based on genetic and immune regulation to fight against infectious diseases, autoimmune-based diseases and cancers. It also provides diagnostic services to the medical community. The company has exclusive patent rights for its products and technologies. Enzo operates in the US, Switzerland and the UK through its wholly owned subsidiaries. The company is headquartered in New York, the US.
Recent Developments
Mar 06, 2009: Enzo Biochem Appoints President Of Enzo Clinical Labs
Sep 08, 2009: Enzo Biochem Appoints Mohan Chellani As Vice President Of Scientific Affairs At Enzo Clinical Labs
Sep 21, 2009: Enzo Biochem Enters Into CRADA With National Eye Institute
Scope
- Provides key company information for business intelligence needs
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- A quick “one-stop-shop†to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial & strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitors’ weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.